Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Binding of RbFox proteins at weak 5'splice site of A2 induces its alternative splicing in non-muscle myosin heavy-chain IIA mRNA. | J Biol Chem | 2026 | 41966273 | PubTator, text mining | PubMed |
| HAO2 inhibits the growth and lipid metabolism of head and neck squamous cell carcinoma by enhancing MYH9 ubiquitination mediated by STUB1 and USP14. | Biochim Biophys Acta Mol Basis Dis | 2026 | 41956260 | PubTator, text mining | PubMed |
| MYH9: Structure, functions, and therapeutic implications in cancer and genetic disorders. | Genes Dis | 2026 | 41953727 | PubTator, text mining | PubMed |
| Influence of Male Body Mass Index on Sperm Quality and In Vitro Fertilization Success Rates. | World J Mens Health | 2026 | 41946656 | PubTator, text mining | PubMed |
| Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway. | Clin Transl Med | 2026 | 41940421 | PubTator, text mining | PubMed |
| Analysis of Platelet Membrane Glycoproteins and The Specific Antibodies in MYH9-Related Diseases. | Int J Gen Med | 2026 | 41938364 | PubTator, text mining | PubMed |
| Hypoxia Modulates Nanovesicle Phenotype and Angiogenic Function From Human Pluripotent Stem Cells. | Proteomics | 2026 | 41937255 | PubTator, text mining | PubMed |
| MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells. | Recent Pat Anticancer Drug Discov | 2026 | 41931669 | PubTator, text mining | PubMed |
| OTUD4 Inhibits Prostate Cancer by Deubiquitinating MYH9. | Oncol Res | 2026 | 41930143 | PubTator, text mining | PubMed |
| Programmed cell death: a promising management for Alzheimer's disease. | Apoptosis | 2026 | 41904723 | PubTator, text mining | PubMed |
| A case report of a family with MYH9 gene mutation-related disease in an ethnic minority group and literature review. | BMC Med Genomics | 2026 | 41904450 | PubTator, text mining | PubMed |
| Proteomic Analysis in Search of New Biomarkers of Immune Thrombocytopenia (ITP)-A Review of Current Data. | Proteomes | 2026 | 41893727 | PubTator, text mining | PubMed |
| Acute E-Cigarette Aerosol Condensate Exposure Disrupts the Transcriptome and Proteome Profiles of Human Bronchial Epithelial BEAS-2B Cells. | Cells | 2026 | 41892316 | PubTator, text mining | PubMed |
| Molecular Switching from Morule to Squamous Metaplasia via p40 and the EBP50/S100A4/Myosin 9 Axis in Endometrial Carcinoma. | Am J Pathol | 2026 | 41881309 | PubTator, text mining | PubMed |
| Myeloid-Derived Grancalcin Promotes Periodontal Inflammation and Pathological Bone Remodeling in Periodontitis. | Adv Sci (Weinh) | 2026 | 41879004 | PubTator, text mining | PubMed |
| Inherited Platelet Disorders During Pregnancy and Delivery: Overview of Management Strategies and Emerging Therapeutic Considerations. | Hematol Rep | 2026 | 41874099 | PubTator, text mining | PubMed |
| Role of Disulfidptosis in the Local Inflammatory Response of Atopic Dermatitis. | Clin Transl Allergy | 2026 | 41872057 | PubTator, text mining | PubMed |
| Gene-by-Sleep Duration Interaction for Glycemic Traits in over 480,000 Individuals. | medRxiv | 2026 | 41867174 | PubTator, text mining | PubMed |
| Cancer-associated SF3B1 mutation suppresses DNA repair by disrupting the organization of nuclear actin network. | Cell Death Dis | 2026 | 41864997 | PubTator, text mining | PubMed |
Isolation methods influence the biological properties of Wharton's Jelly-derived mesenchymal stem cells: A comparative study of yield, viability, proliferation, differentiation potential, and proteomic profiles. | PLoS One | 2026 | 41860834 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=3